Incorporated

Mastercard Incorporated to issue quarterly dividend of $ 0.44 (NYSE: MA)

Embedded Mastercard (NYSE: MA) declared a quarterly dividend on Monday, September 20, RTT News reports. Shareholders of record on Friday October 8 will receive a dividend of 0.44 per share from the credit service provider on Tuesday November 9. This represents a dividend of $ 1.76 on an annualized basis and a return of 0.52%.

Mastercard has increased its dividend by 81.8% over the past three years.

NYSE MA traded at $ 3.35 on Monday, reaching $ 339.69. The stock had a trade volume of 3,955,697 shares, compared to its average volume of 3,786,775. The company has a 50-day moving average price of $ 364.64 and a 200-day moving average price of. $ 368.60. The company has a current ratio of 1.33, a quick ratio of 1.33, and a debt ratio of 2.03. Mastercard has a one-year minimum of $ 281.20 and a one-year maximum of $ 401.50. The company has a market cap of $ 335.20 billion, a price / earnings ratio of 47.19, a P / E / G ratio of 1.98 and a beta of 1.16.

Mastercard (NYSE: MA) last reported its quarterly results on Thursday, July 29. The credit services provider reported earnings per share of $ 1.95 for the quarter, beating analyst consensus estimates of $ 1.72 by $ 0.23. Mastercard had a return on equity of 109.48% and a net margin of 43.22%. The company posted revenue of $ 4.53 billion in the quarter, compared to $ 4.35 billion expected by analysts. On average, analysts predict that Mastercard will post 8.11 earnings per share for the current fiscal year.

(A d)

The explosive rise in tech stocks we saw in 2020 is just the start …

“The Earnings Whisperer” Louis Navellier posted a video detailing several key steps he believes every American should take right now.

MA has been the subject of several research analyst reports. Raymond James increased his Mastercard price target from $ 428.00 to $ 453.00 and gave the stock an “outperformance” rating in a research report on Friday, July 30. Daiwa Capital Markets upgraded Mastercard from an “outperformance” rating to a “neutral” rating and set a price target of $ 385.00 for the company. in a research report on Thursday August 12. Mizuho raised his price target on Mastercard from $ 435.00 to $ 450.00 and gave the stock a “buy” rating in a research report on Monday, August 2. Morgan Stanley raised its Mastercard price target from $ 444.00 to $ 451.00 and rated the stock “overweight” in a research report published on Friday, July 30. Finally, Wells Fargo & Company raised its Mastercard price target from $ 430.00 to $ 440.00 and rated the stock “overweight” in a research report released on Friday, July 30. Two equity research analysts rated the stock with a conservation rating and nineteen gave the stock a buy rating. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $ 418.48.

In addition, President Ajay Banga sold 60,000 shares in a transaction on Wednesday July 14. The stock was sold for an average price of $ 390.34, for a total value of $ 23,420,400.00. The transaction was disclosed in a file with the SEC, accessible through the SEC’s website. In addition, CFO J. Mehra Sachin sold 7,838 shares in a trade on Friday July 30. The shares were sold for an average price of $ 385.42, for a total value of $ 3,020,921.96. Following the completion of the transaction, the CFO now directly owns 20,320 shares of the company, valued at approximately $ 7,831,734.40. Disclosure of this sale can be found here. In the past 90 days, insiders have sold 876,377 shares of the company valued at $ 330,177,910. 0.33% of the shares are held by insiders of the company.

An institutional investor recently increased his position in Mastercard shares. Morgan Stanley increased its position in Mastercard Incorporated (NYSE: MA) by 1.4% in the 2nd quarter, according to its latest filing with the SEC. The fund held 18,779,658 shares of the credit service provider after purchasing an additional 259,715 shares during the period. Mastercard includes 0.9% of Morgan Stanley’s holdings, making the stock its 10th position. Morgan Stanley owned approximately 1.90% of Mastercard worth $ 6,856,264,000 at the end of the most recent quarter. 73.97% of the shares are held by institutional investors.

Mastercard Company Profile

Mastercard, Inc. operates like a technology company. The company engages in the payments industry that connects consumers, financial institutions, merchants, governments and businesses. It offers payment solutions for the development and implementation of credit, debit, prepaid, commercial and payment programs.

Read more: Double registration What you need to know

Dividend history for Mastercard (NYSE: MA)

This instant news alert was powered by narrative science technology and MarketBeat financial data to provide readers with the fastest, most accurate reports. This story was reviewed by the MarketBeat editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Should you invest $ 1,000 in Mastercard now?

Before you consider Mastercard, you’ll want to hear this.

MarketBeat tracks Wall Street’s top-rated and top-performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts quietly whisper to their clients to buy now before the larger market takes hold of… and Mastercard was not on the list.

While Mastercard currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.

See the 5 actions here

Source link

Is Iron Mountain Incorporated (NYSE: IRM) popular among institutions?

A look at the shareholders of Iron Mountain Incorporated (NYSE: IRM) can tell us which group is more powerful. Insiders often own a large portion of younger and smaller companies, while larger companies tend to have institutions as shareholders. We also tend to see a decrease in insider ownership in companies that were previously owned by the state.

Iron Mountain is a pretty big company. It has a market capitalization of 13 billion US dollars. Normally, institutions would own a significant share of a company of this size. Looking at our data on ownership groups (below), it appears that institutions are visible on the share register. Let’s take a closer look at what different types of shareholders can tell us about Iron Mountain.

Check out our latest review for Iron Mountain

NYSE Ownership Breakdown: IRM September 20, 2021

What does institutional ownership tell us on Iron Mountain?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it’s included in a major index. . We would expect most businesses to have some institutions listed, especially if they are growing.

Iron Mountain already has institutions listed in the share register. Indeed, they hold a respectable stake in the company. This suggests some credibility among professional investors. But we cannot rely on this fact alone because institutions sometimes make bad investments, like everyone else. If several institutions change their mind about a stock at the same time, you could see the stock price drop quickly. So it’s worth checking out Iron Mountain’s earnings history below. Of course, the future is what really matters.

profit and revenue growth
NYSE: IRM Earnings and Revenue Growth September 20, 2021

Since institutional investors own more than half of the issued shares, the board will likely need to pay attention to their preferences. We note that the hedge funds do not have a significant investment in Iron Mountain. Looking at our data, we can see that the largest shareholder is The Vanguard Group, Inc. with 17% of the shares outstanding. For context, the second largest shareholder owns around 11% of the outstanding shares, followed by an 8.0% stake by the third largest shareholder.

Looking at the register of shareholders, we can see that 51% of the property is controlled by the top 11 shareholders, which means that no shareholder has a controlling interest in the property.

Institutional ownership research is a good way to assess and filter the expected performance of a stock. The same can be achieved by studying the feelings of analysts. Many analysts cover the stock, so it can be interesting to see what they are forecasting as well.

Iron Mountain Insider Property

The definition of an insider may differ slightly from country to country, but board members still count. The management of the company manages the company, but the CEO will report to the board of directors, even if he is a member of the board.

Most view insider ownership as a positive, as it can indicate that the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.

We can see that the insiders own shares in Iron Mountain Incorporated. Insiders own $ 139 million in shares (at current prices). Most would say it shows a good alignment of interests between shareholders and the board. Still, it might be worth checking out if these insiders have sold.

General public property

With 19% ownership, the general public has some influence on Iron Mountain. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in line with other large shareholders.

Next steps:

While it is worth considering the different groups that own a business, there are other factors that are even more important. Concrete example: we have spotted 4 warning signs for Iron Mountain you need to be aware of it, and one of them is a bit of a concern.

If you’d rather find out what analysts are predicting in terms of future growth, don’t miss this free analyst forecast report.

NB: The figures in this article are calculated from data for the last twelve months, which refer to the 12-month period ending on the last date of the month of date of the financial statement. This may not be consistent with the figures in the annual report for the entire year.

When trading Iron Mountain or any other investment, use the platform considered by many to be the gateway for professionals to the global market, Interactive Brokers. You get the cheapest * trading on stocks, options, futures, forex, bonds and funds from around the world from a single integrated account. Promoted

This Simply Wall St article is general in nature. We provide commentary based on historical data and analyst forecasts using only unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell shares and does not take into account your goals or your financial situation. Our aim is to bring you long-term, targeted analysis based on fundamental data. Note that our analysis may not take into account the latest announcements from price sensitive companies or qualitative material. Simply Wall St has no position in the mentioned stocks.
*Interactive Brokers Ranked Least Expensive Broker By StockBrokers.com Online Annual Review 2020

Do you have any feedback on this item? Are you worried about the content? Get in touch with us directly. You can also send an email to the editorial team (at) simplywallst.com.

Source link

Marvel’s Spider-Man 2 fans want PS5 sequel to incorporate Batman: Arkham Knight feature

Although the original Marvel’s Spider-Man and its derivative component, Marvel’s Spider-Man: Miles Morales, were both great in their own ways, that hasn’t stopped many fans from pondering what improvements developer Insomniac Games could make to Marvel’s Spider-Man 2. The sequel, which was announced for PlayStation 5 earlier this month, isn’t set to launch until 2023. Despite this, a number of fans have started to look to other superhero games. to come up with ideas that could be implemented in the next episode.

In a recent thread on the Marvel’s Spider-Man subreddit, a user by the name of u / daredevilman999 suggested that the next sequel should borrow something from Batman: Knight of Arkham. In particular, this user very much appreciated an aspect of Knight of arkham it would allow them to revisit the bad guys they had already thrown in jail. While those prison cells at the start of Knight of arkham were largely empty, as the story progressed the cells began to be populated by the villains that Batman was tidying up. Likewise, they suggested that Insomniac should put a feature like this in Marvel’s Spider-Man 2.

“I hope Spider-man 2 has a characteristic similar to Knight of arkham where you can visit the villains you defeated in prison, “the post said on Reddit.” I think that would be so cool and motivate the player to move the story forward. “

After sharing this idea, the post immediately jumped to the top of the Marvel’s Spider-Man subreddit and has become something that many fans have started to rally behind. While some suggested that it wouldn’t be very in character for Spider-Man to visit villains in jail that he put in jail, others thought it would be another cool way for Spidey to have extra jokes with his rogue gallery. .

As mentioned earlier, the main drawback with Marvel’s Spider-Man 2 at this point is that we probably won’t see or hear about the project in the near future. As such, it’s unclear whether a feature like this will end up making it into the game. Still, whenever the game releases in 2023 on PlayStation 5, we’ll have to see if Insomniac has decided to listen to the fans. or not in this regard.

[H/T Game Rant]
Source link

Nigeria to incorporate state-owned oil company NNPC, appointed by board

Nigerian President Muhammadu Buhari speaks at a press conference while visiting Pretoria, South Africa, October 3, 2019. REUTERS / Siphiwe Sibeko / File Photo

ABUJA, Sept. 19 (Reuters) – Nigerian President Muhammadu Buhari on Sunday said he had appointed a board of directors for state-owned oil company NNPC and ordered it to be incorporated within six months, a move that could allow him to sell stocks in the future.

Buhari, who is also petroleum minister, signed an oil bill last month that has been in the works for nearly two decades, aimed at reorganizing the sector and turning the state oil company into a private enterprise. Read more

The new oil law requires the NNPC to be incorporated within six months, Buhari said in a statement, appointing Ifeanyi Ararume as chairman of the NNPC and its current chief executive Mele Kyari as the head of the company.

Kyari said the NNPC may consider an initial public offering (IPO) within three years. Incorporation could pave the way for the NNPC to sell shares. Read more

Buhari said last month that the NNPC made its first profit in 44 years in 2020.

Reporting by Felix Onuah; Writing by Chijioke Ohuocha; Editing by Alexander Smith and Edmund Blair

Our Standards: The Thomson Reuters Trust Principles.

Source link

Zacks: Brokerages Expect Corcept Therapeutics Incorporated (NASDAQ: CORT) to Report Earnings of $ 0.19 per Share

Stock analysts expect Corcept Therapeutics Incorporated (NASDAQ: CORT) to report earnings per share of $ 0.19 for the current quarter, according to Zacks. Two analysts have released earnings estimates for Corcept Therapeutics, with estimates ranging from $ 0.18 to $ 0.21. Corcept Therapeutics posted earnings of $ 0.17 per share in the same quarter of last year, which would indicate a positive growth rate of 11.8% year-over-year. The company is expected to release its next quarterly results on Tuesday, November 2.

According to Zacks, analysts expect Corcept Therapeutics to report annual earnings of $ 0.82 per share for the current year, with EPS estimates ranging from $ 0.77 to $ 0.88. For next year, analysts expect the company to report earnings of $ 0.97 per share, with EPS estimates ranging from $ 0.92 to $ 1.03. Zacks’ BPA calculations are an average based on a survey of sales-side research analysts who cover Corcept Therapeutics.

Corcept Therapeutics (NASDAQ: CORT) last reported its quarterly results on Thursday, July 29. The biotech company reported EPS of $ 0.21 for the quarter, beating the consensus estimate of $ 0.14 by $ 0.07. Corcept Therapeutics generated a net margin of 28.45% and a return on equity of 19.08%. The company posted revenue of $ 91.59 million in the quarter, compared to analysts’ expectations of $ 85.83 million.

A number of research companies have weighed in on CORT. HC Wainwright reaffirmed a “buy” note on shares of Corcept Therapeutics in a research report on Friday, July 30. TheStreet upgraded Corcept Therapeutics’ shares from a “c +” rating to a “b-” rating in a research report on Thursday, July 8. The UBS Group reaffirmed a “positive” rating on the shares of Corcept Therapeutics in a research report on Tuesday 22 June. Finally, Zacks Investment Research upgraded Corcept Therapeutics shares from a “sell” rating to a “keep” rating and set a price target of $ 24.00 for the company in a research report released on Wednesday. July 7.

(A d)

The explosive rise in tech stocks we saw in 2020 is just the start …

“The Earnings Whisperer” Louis Navellier posted a video detailing several key steps he believes every American should take right now.

In other news, insider Gary Charles Robb sold 47,853 shares in a trade dated Wednesday, September 15. The shares were sold at an average price of $ 20.49, for a total trade of $ 980,507.97. The sale was disclosed in a legal file with the SEC, which is available at this link. Additionally, principal Daniel N. Swisher, Jr. sold 7,500 shares in a trade dated Thursday, September 2. The stock was sold at an average price of $ 21.70, for a total trade of $ 162,750.00. As a result of the sale, the director now directly owns 7,500 shares of the company, valued at approximately $ 162,750. Disclosure of this sale can be found here. In the past ninety days, insiders have sold 136,694 shares of the company valued at $ 2,894,971. 16.50% of the shares are currently held by insiders.

Institutional investors have recently changed their positions in the company. Ameriprise Financial Inc. increased its position in Corcept Therapeutics by 5.5% in the 1st quarter. Ameriprise Financial Inc. now owns 470,555 shares of the biotech company valued at $ 11,194,000 after purchasing an additional 24,585 shares in the last quarter. UBS Group AG increased its stake in Corcept Therapeutics by 1.5% in the 1st quarter. UBS Group AG now owns 41,569 shares of the biotech company valued at $ 989,000 after purchasing an additional 621 shares in the last quarter. Principal Financial Group Inc. increased its stake in Corcept Therapeutics by 0.3% in the 1st quarter. Principal Financial Group Inc. now owns 746,416 shares of the biotech company valued at $ 17,757,000 after purchasing an additional 2,400 shares during the period. Burney Co. increased its stake in Corcept Therapeutics by 2.3% in the 2nd quarter. Burney Co. now owns 386,608 shares of the biotech company valued at $ 8,506,000 after purchasing an additional 8,781 shares during the period. Finally, Victory Capital Management Inc. increased its stake in Corcept Therapeutics by 4.1% in the second quarter. Victory Capital Management Inc. now owns 53,489 shares of the biotech company valued at $ 1,176,000 after purchasing an additional 2,093 shares during the period. Institutional investors hold 68.64% of the shares of the company.

CORT shares traded down $ 0.12 during trading hours on Friday, reaching $ 20.51. The stock had a trade volume of 2,000,802 shares, compared to its average volume of 556,771. The company has a 50-day moving average price of $ 20.92 and a 200-day moving average price of 22. $ 17. Corcept Therapeutics has a 52 week low of $ 16.42 and a 52 week high of $ 31.18. The company has a market cap of $ 2.38 billion, a price-to-earnings ratio of 26.99, a PEG ratio of 1.80, and a beta of 0.69.

About Corcept Therapeutics

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company engaged in the discovery, development and commercialization of drugs to treat serious metabolic, oncological and psychiatric disorders. He is focusing on drug development for disorders associated with a steroid hormone called cortisol.

Further reading: Mutual funds are not immune to market timing

Get a free copy of Zacks’ research report on Corcept Therapeutics (CORT)

For more information on Zacks Investment Research’s research offerings, visit Zacks.com

Corcept Therapeutics Revenue History and Estimates (NASDAQ: CORT)

This instant news alert was powered by storytelling technology and financial data from MarketBeat to provide readers with the fastest, most accurate reports. This story was reviewed by the MarketBeat editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Should you invest $ 1,000 in Corcept Therapeutics now?

Before you consider Corcept Therapeutics, you’ll want to hear this.

MarketBeat tracks Wall Street’s top-rated and top-performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat identified the five stocks that top analysts quietly whisper to their clients to buy now before the larger market takes hold of … and Corcept Therapeutics was not on the list.

Although Corcept Therapeutics currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better bids.

See the 5 actions here

Source link

Council of the Township of Woodlands meets; discusses incorporation, federal funding and more

New

Through |


The Woodlands Township Board of Directors held its regular meeting on Thursday, September 16, 2021 at The Woodlands Township Townhall, 2801 Technology Forest Boulevard in The Woodlands, Texas.

The main talking points are highlighted below:

  • Received, reviewed and acted on the Incorporation Planning Study Questions. Woodlands Township Assistant General Manager, Finance and Administration Monique Sharp gave a presentation to township administrators to clarify the misinformation presented in the community, primarily related to the financial model and law enforcement funding being used in developing the maximum initial tax rate for incorporation ballot proposals. . The presentation is available at this link: www.thewoodlandstownship-tx.gov/ArchiveCenter/ViewFile/Item/11720
  • Discussion of the coronavirus pandemic (COVID-19), including the lack of federal funding not received by the Township of Woodlands. State Senator Brandon Creighton recently submitted a request to the Texas Attorney General’s Office for an opinion on whether local governments in counties over 500,000 people should receive CARES funds from Texas or their respective county. As an eligible recipient for CARES funds, the township expected to receive $ 6.8 million in federal emergency funding, but to date it has received less than $ 1 million. The township council discussed its efforts to advocate with state and local authorities to secure the rest of the CARES funds for the township. The Board also received an update regarding ongoing advocacy with the Treasury for federal funding under the American Rescue Plan Act (ARPA). The Treasury established guidelines and funding allocations earlier this summer for local governments in accordance with the legislation. Unfortunately, the Treasury has narrowly defined the conditions of eligibility for funding, limiting relief only to established places and minor civilian divisions. As an unincorporated government, the Township of Woodlands is missing up to $ 30 million in ARPA relief. The township worked with Congress and the federal administration to remedy the oversight.

The township portion of Montgomery County still has $ 5.8 million in eligible expenses not reimbursed under guidelines issued by the federal government. In early 2021, the US president enacted the American Rescue Plan Act (ARPA) providing $ 350 billion in additional emergency financial assistance to eligible local communities. ARPA continued the federal government’s response started under the CARES Act to provide broad-based direct funding to local governments of all sizes. The US Treasury has established guidelines and funding allocations for local governments in accordance with the law. Unfortunately, the Treasury has narrowly defined the conditions of eligibility for funding, limiting relief only to established places and minor civilian divisions. As an unincorporated government, the Township of Woodlands lacks up to $ 30 million in ARPA support, while counties and communities across the region receive funds. The township worked with Congress and the federal administration to remedy the oversight.

Advertising

Following the recognition of public officials and public comment, the Board of Directors issued the following proclamations:

  • In support of International Walk to School Month, a program that promotes clean air, healthy children and families, a sense of community and use safe community trails, exemplifying community values. Since 2005, The Woodlands Township has ranked among the top two communities in Texas with the most participating schools.
  • In support of National Night Out, an annual community building campaign that fosters police-community partnerships and neighborhood camaraderie to make neighborhoods safer and better in which to live.
  • In recognition of National Dyslexia Awareness Month, which promotes a future for all people struggling with dyslexia and other related reading differences so that they can have richer, more robust lives and have access to tools and the resources they need.
  • In support of Imagine a Day Without Water, a national education campaign that brings together diverse stakeholders to highlight how essential water conservation is.
  • In recognition of Constitution Week, September 17-23, and recognizing September 17, 2021 as the 234e anniversary of the elaboration of the Constitution of the United States of America by the Constitutional Convention.

On the Consent Agenda, the Board of Directors approved the following:

  • Administrative reports for community services.
  • Administrative reports for transport.
  • Reports for the Woodlands Fire Department.
  • Purchase and installation of play equipment for Bonny Branch Park.

On the regular agenda, the Board of Directors took the following actions:

  • Originally placed on the Consent agenda, Council received a report of recent criminal activity in The Woodlands as part of Administrative Reports for Law Enforcement and the Community.
  • The Commission postponed action on the purchase of streetscape maintenance equipment.

For more information on The Woodlands Township, or to view the full meeting, please visit www.thewoodlandstownship-tx.gov, or call 281-210-3800.

Photo credit: Township of Woodlands; The Woodlands Township Board of Directors held its regular meeting on Thursday, September 16, 2021 at The Woodlands Township Townhall, 2801 Technology Forest Boulevard in The Woodlands, Texas. The Council issued proclamations in honor of International Walk to School Month, National Night, National Dyslexia Month, Imagine a Day Without Water and Constitution Week.

Source: Township of Woodlands

Advertising


Source link